Latest AI and machine learning research in acute coronary syndrome for healthcare professionals.
Aortic aneurysms, including abdominal (AAA) and thoracic (TAA), pose significant challenges due to their rupture risk and complex pathophysiology. While aspirin has been proposed to manage aneurysm progression, evidence remains limited. This retrospective, single-center study used AI-driven methods to examine the association between aspirin therapy and aneurysm growth. The study, at the University...
In spite of evidence and recommendations reflecting the importance of pharmacogenomic testing, most prescriptions are still given without testing. We demonstrate the real world implications of the use of testing and evaluate adverse events and outcomes in individuals who did not receive pharmacogenomic testing for clopidogrel. We analyzed ~100K individuals with paired EHR and exome sequencing data...
Thrombotic Antiphospholipid Syndrome (TAPS) is an autoimmune disorder associated with a high risk of recurrent thromboembolic events. Despite advances...
Accurately differentiating severe from non-severe COVID-19 clinical types is critical for the healthcare system to optimize workflow. Current techniqu...
Randomized controlled trials (RCTs) provide the highest level of clinical evidence but are often limited by cost, time, and ethical constraints. Emula...
Allostatic load refers to the cumulative burden of stress and life events that involve the interaction of various physiological systems at differing l...
Chest pain is among the most common chief complaints in Emergency Departments (EDs), and differentiating acute coronary syndrome from low-risk chest p...
Precision-guided dual antiplatelet therapy (DAPT) duration post-percutaneous coronary intervention (PCI) remains a clinical challenge. Current risk st...
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, with acute myocardial infarction (AMI) contributing to over 100,000 dea...
Pre-procedural risk prediction of 30-day all-cause mortality after percutaneous coronary intervention (PCI) aids in clinical decision-making and bench...
Standardized assessment of clinical quality measures from electronic health records (EHRs) is challenging because information is fragmented across str...
Thrombophilia diagnosis and management rely on the nuanced interpretation of clinical history, risk factors, and laboratory data, yet significant vari...
Pericardial effusion can progress to life-threatening cardiac tamponade when large or rapidly accumulating, yet early diagnosis is frequently delayed ...
Postoperative new-onset deep vein thrombosis (PNO-DVT) of the lower extremities represents a prevalent and serious clinical complication following pel...
Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is conventionally diagnosed using electrocardiography and serial blood biomarker measureme...
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major contributor to global morbidity and mortality, particularly during acute exacerbat...
Early detection of surgical complications allows for timely therapy and proactive risk mitigation. Machine learning (ML) can be leveraged to identif...
BACKGROUND: The PRAISE (PRedicting with Artificial Intelligence riSk aftEr acute coronary syndrome) score is a machine learning-based model for predic...
Neuropathologic changes of Alzheimer disease (AD) including Aβ accumulation and neuroinflammation are frequently observed in the cerebral cortex of pa...
Anterior ST-segment elevation myocardial infarction (STEMI) is associated with severe adverse remodeling and increased mortality rates. In this stud...